Analogously to 5-AMQ, in C57BL/6 mice with high-fat diet-induced obesity, 6MeONa treatment caused a reduction in body weight, improved insulin sensitivity and normalized glucose tolerance to the level of lean control mice [37]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.